NEW HAVEN, Conn., March 14, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, announced that Michael D. Kishbauch, President and Chief Executive Officer of Achillion, will be presenting a corporate overview and update on the Company's programs in HIV, HCV and serious bacterial infections at the 28th Annual Cowen & Company Healthcare Conference on Monday, March 17, 2008 at 3:15 p.m. at The Boston Marriott Copley Place.
